The expression of IL-6 was observed to be 2.4 fold upregulated at the protein level (Fig 3B and 3C) and that for Stat3 about 3.5 fold upregulated at transcript level (Fig 3A) in DEN-induced hepatic cancer as compared to control mice. The gene discussed is STAT3; the disease is liver cancer.